Deutor-Garcia L, Chamorro-Santos C, Fraile-Ruiz L, Pozo-Kreilinger JJ, Hernández-Vila C. Primary malignant PEComa of the mandible. Report of an unusual case. J Clin Exp Dent. 2021;13(9):e957-60.

doi:10.4317/jced.58347

___________

References

1. Hornick JL FC. PEComa: what do we know so far? Histopathology. 2006;48:75-82. https://doi.org/10.1111/j.1365-2559.2005.02316.x PMid:16359539

2. Schmiester M, Dolnik A, Kornak U, Pfitzner B, Hummel M, Treue D, et al. JTFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanismsan. J Pathol Clin Res. 2021;7:3-9. https://doi.org/10.1002/cjp2.187 PMid:33180365 PMCid:PMC7737753

3. Nair AG, Gore SS, Ganvir AY, Adulkar NG, Gopinathan I, Murthy AK, et al. Giant Perivascular Epithelioid Cell Tumor of the Orbit: A Clinicopathological Analysis and Review of the Literature. Ocul Oncol Pathol. 2018;4:272-9. https://doi.org/10.1159/000484425 PMid:30320097 PMCid:PMC6167662

4. Selvaggi F, Risio D, Claudi R, Cianci R, Angelucci D, Pulcini D, et al. Malignant PEComa: a case report with emphasis on clinical and morphological criteria. BMC Surg. 2011;11:3. https://doi.org/10.1186/1471-2482-11-3 PMid:21272348 PMCid:PMC3042371

5. Untrauer JB, Giannini PJ, Talmon GA JS. Malignant PEComa involving the mandible: report of a unique case. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117:e3-8. https://doi.org/10.1016/j.oooo.2012.03.018 PMid:22901659

6. Lao IW, Yu L, Wang J. Malignant perivascular epithelioid cell tumor (PEComa) of the femur: a case report and literature review. Diagn Pathol. 2015;10:54. https://doi.org/10.1186/s13000-015-0292-2 PMid:26022435 PMCid:PMC4446961

7. Wagner AJ, Malinowska-Kolodziej I, Morgan JA, Qin W, Fletcher CD, Vena N, et al. Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol. 2010;10;28:835-40. https://doi.org/10.1200/JCO.2009.25.2981 PMid:20048174 PMCid:PMC4810029

8. Zhou L, Xu H, Zhou J, Dong L, Zhang P, Yang X, et a. Nuclear TFE3 expression is a diagnostic marker for Desmoid-type fibromatosis. Diagn Pathol. 2019;14:34. https://doi.org/10.1186/s13000-019-0814-4 PMid:31043173 PMCid:PMC6495536

9. Yang B, Duan H, Cao W, Guo Y, Liu Y, Sun L, et al. Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology, immunohistochemistry, and FISH analysis. Mod Pathol. 2019;32:1521-35. https://doi.org/10.1038/s41379-019-0283-z PMid:31175325

10. Aldera AP PK. Clear Cell Sarcoma of the Kidney. Arch Pathol Lab Med. 2020;144:119-23. https://doi.org/10.5858/arpa.2018-0353-RS PMid:30917048

11. Tobouti PL, Pigatti FM, Martins-Mussi MC, Sedassari BT O-M de SS. Extra-tongue oral granular cell tumor: Histological and immunohistochemical aspect. Med Oral Patol Oral Cir Bucal. 2017;22:e31-5. https://doi.org/10.4317/medoral.21401 PMid:27918739 PMCid:PMC5217494

12. Rosenberg A AM. Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment. Curr Treat Options Oncol. 2018;19:19. https://doi.org/10.1007/s11864-018-0536-y PMid:29546487

13. Christopher Z, Binitie O, Henderson-Jackson E, Perno J MR. Langerhans cell histiocytosis of bone in an adult: A case report. Radiol Case Rep. 2018;13:310-4. https://doi.org/10.1016/j.radcr.2017.11.020 PMid:29904462 PMCid:PMC5999879

14. Yamashita K FC. PEComa presenting in bone: clinicopathologic analysis of 6 cases and literature review. Am J Surg Pathol. 2010;34:1622-9. https://doi.org/10.1097/PAS.0b013e3181f5974f PMid:20975340

15. Fabbroni C, Sbaraglia M SR. Medical treatment of advanced malignant perivascular epithelioid cell tumors. Curr Opin Oncol. 2020;32:301-6.
https://doi.org/10.1097/CCO.0000000000000649
PMid:32541317